DWM
UTHR icon

Darwin Wealth Management’s United Therapeutics UTHR Stock Holding History

Darwin Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.67K Hold
16
– – ﹤0.01% 395
2026
Q1 		$9.49K Hold
16
– – ﹤0.01% 365
2025
Q4 		$7.8K Hold
16
– – ﹤0.01% 401
2025
Q3 		$6.71K Hold
16
– – ﹤0.01% 405
2025
Q2 		$4.6K Hold
16
– – ﹤0.01% 420
2025
Q1 		$5.64K Hold
16
– – ﹤0.01% 430
2024
Q4 		$5.64K Hold
16
– – ﹤0.01% 430
2024
Q3 		$5.73K Buy
+16
New +$5.41K ﹤0.01% 443
2020
Q2 		– Sell
-16
Closed -$1K – 744
2020
Q1 		$1K Buy
+16
New +$1.52K ﹤0.01% 771

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Darwin Wealth Management's UTHR Position: Q2 2026 in Review

Darwin Wealth Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 16 shares worth $8.67K. The position accounts for ﹤0.01% of the portfolio, ranked #395.

Darwin Wealth Management first reported a position in UTHR in Q1 2020 and has held it in 9 quarters since. The position peaked at $9.49K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Darwin Wealth Management held 16 shares of United Therapeutics worth $8.67K as of Q2 2026.
  • Darwin Wealth Management left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #395 holding.
  • Darwin Wealth Management first reported a position in United Therapeutics in Q1 2020 and has held it in 9 quarters since.
  • Darwin Wealth Management's United Therapeutics position peaked at $9.49K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.